Picture of Cellebrite DI logo

CLBT — Cellebrite DI News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousMid CapHigh Flyer

Israel's Cellebrite Q1 revenue rises 19%, beats estimates

Overview

Israel digital forensics firm's Q1 revenue grew 19%, beating analyst expectations

Adjusted EBITDA for Q1 beat analyst estimates; net income missed expectations

Company closed SCG Canada acquisition, expanding drone forensics capabilities

Outlook

Cellebrite expects Q2 revenue of $130 mln to $133 mln

Company sees full-year 2026 revenue of $565 mln to $571 mln

Cellebrite projects Q2 ARR of $510 mln to $513 mln

Result Drivers

SUBSCRIPTION GROWTH - Q1 subscription revenue rose 23% year-over-year, supporting overall revenue growth

NEW PRODUCT OFFERINGS - Co cited strong customer response to new AI-powered solutions, including Guardian Investigate and Genesis, as contributing to results

DRONE FORENSICS EXPANSION - Acquisition of SCG Canada broadened digital forensics capabilities to include drones, an emerging device category

Company press release: ID:nPn18HqBDa

Key Details

MetricBeat/MissActualConsensus Estimate
Q1 RevenueBeat$128.3 mln$126.85 mln (7 Analysts)
Q1 Net IncomeMiss$10.94 mln$23.91 mln (4 Analysts)
Q1 Adjusted EBITDABeat$30.62 mln$27.16 mln (6 Analysts)
Q1 Gross Margin82.50%
Q1 Cash Flow from Operating Activities$19.89 mln
Q1 Operating Income$9.12 mln
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", no "hold" and no "sell" or "strong sell" The average consensus recommendation for the software peer group is "buy" Wall Street's median 12-month price target for Cellebrite DI Ltd is $21.00, about 73.6% above its May 13 closing price of $12.10 The stock recently traded at 21 times the next 12-month earnings vs. a P/E of 27 three months ago For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Cellebrite DI

See all news